390 related articles for article (PubMed ID: 31585213)
1. Challenges and pitfalls in the development of liposomal delivery systems for cancer therapy.
Moosavian SA; Bianconi V; Pirro M; Sahebkar A
Semin Cancer Biol; 2021 Feb; 69():337-348. PubMed ID: 31585213
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in liposome formulations for breast cancer therapeutics.
Yang B; Song BP; Shankar S; Guller A; Deng W
Cell Mol Life Sci; 2021 Jul; 78(13):5225-5243. PubMed ID: 33974093
[TBL] [Abstract][Full Text] [Related]
3. Liposomal drug delivery systems: from concept to clinical applications.
Allen TM; Cullis PR
Adv Drug Deliv Rev; 2013 Jan; 65(1):36-48. PubMed ID: 23036225
[TBL] [Abstract][Full Text] [Related]
4. Liposomes as a Promising Ultrasound-Triggered Drug Delivery System in Cancer Treatment.
Salkho NM; Turki RZ; Guessoum O; Martins AM; Vitor RF; Husseini GA
Curr Mol Med; 2017; 17(10):668-688. PubMed ID: 29663885
[TBL] [Abstract][Full Text] [Related]
5. Recent advances and clinical translation of liposomal delivery systems in cancer therapy.
Chen J; Hu S; Sun M; Shi J; Zhang H; Yu H; Yang Z
Eur J Pharm Sci; 2024 Feb; 193():106688. PubMed ID: 38171420
[TBL] [Abstract][Full Text] [Related]
6. Advances in the Application of Liposomal Nanosystems in Anticancer Therapy.
Xiao D; Zhou R
Curr Stem Cell Res Ther; 2021; 16(1):14-22. PubMed ID: 32324519
[TBL] [Abstract][Full Text] [Related]
7. Theranostic liposomes for cancer diagnosis and treatment: current development and pre-clinical success.
Muthu MS; Feng SS
Expert Opin Drug Deliv; 2013 Feb; 10(2):151-5. PubMed ID: 23061654
[TBL] [Abstract][Full Text] [Related]
8. Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics.
Marchal S; El Hor A; Millard M; Gillon V; Bezdetnaya L
Drugs; 2015 Sep; 75(14):1601-11. PubMed ID: 26323338
[TBL] [Abstract][Full Text] [Related]
9. Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities.
Belfiore L; Saunders DN; Ranson M; Thurecht KJ; Storm G; Vine KL
J Control Release; 2018 May; 277():1-13. PubMed ID: 29501721
[TBL] [Abstract][Full Text] [Related]
10. Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.
Yingchoncharoen P; Kalinowski DS; Richardson DR
Pharmacol Rev; 2016 Jul; 68(3):701-87. PubMed ID: 27363439
[TBL] [Abstract][Full Text] [Related]
11. Extracellular vesicles in cancer nanomedicine.
Tarasov VV; Svistunov AA; Chubarev VN; Dostdar SA; Sokolov AV; Brzecka A; Sukocheva O; Neganova ME; Klochkov SG; Somasundaram SG; Kirkland CE; Aliev G
Semin Cancer Biol; 2021 Feb; 69():212-225. PubMed ID: 31421263
[TBL] [Abstract][Full Text] [Related]
12. Surface-active liposomes for targeted cancer therapy.
Sofou S
Nanomedicine (Lond); 2007 Oct; 2(5):711-24. PubMed ID: 17976032
[TBL] [Abstract][Full Text] [Related]
13. Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles.
Alavi M; Hamidi M
Drug Metab Pers Ther; 2019 Feb; 34(1):. PubMed ID: 30707682
[TBL] [Abstract][Full Text] [Related]
14. Liposomal curcumin and its application in cancer.
Feng T; Wei Y; Lee RJ; Zhao L
Int J Nanomedicine; 2017; 12():6027-6044. PubMed ID: 28860764
[TBL] [Abstract][Full Text] [Related]
15. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
[TBL] [Abstract][Full Text] [Related]
16. Nanomedicines based drug delivery systems for anti-cancer targeting and treatment.
Jain V; Jain S; Mahajan SC
Curr Drug Deliv; 2015; 12(2):177-91. PubMed ID: 25146439
[TBL] [Abstract][Full Text] [Related]
17. Liposomal nanomedicines in the treatment of prostate cancer.
Kroon J; Metselaar JM; Storm G; van der Pluijm G
Cancer Treat Rev; 2014 May; 40(4):578-84. PubMed ID: 24216226
[TBL] [Abstract][Full Text] [Related]
18. Liposomes a vesicular nanocarrier: potential advancements in cancer chemotherapy.
Kumar P; Gulbake A; Jain SK
Crit Rev Ther Drug Carrier Syst; 2012; 29(5):355-419. PubMed ID: 22876808
[TBL] [Abstract][Full Text] [Related]
19. Companion Diagnostic
Lee H; Gaddy D; Ventura M; Bernards N; de Souza R; Kirpotin D; Wickham T; Fitzgerald J; Zheng J; Hendriks BS
Theranostics; 2018; 8(9):2300-2312. PubMed ID: 29721081
[TBL] [Abstract][Full Text] [Related]
20. Implications of nanotechnology for the treatment of cancer: Recent advances.
Klochkov SG; Neganova ME; Nikolenko VN; Chen K; Somasundaram SG; Kirkland CE; Aliev G
Semin Cancer Biol; 2021 Feb; 69():190-199. PubMed ID: 31446004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
